Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
2016 ◽
Vol 100
(8)
◽
pp. e43-e44
◽
2017 ◽
Vol 21
(4)
◽
pp. 205
◽
2020 ◽
Vol 12
(4)
◽
pp. 149-158